Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®
On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Challenges and Strategies for the Application of Omics and Spatial Technologies
A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Clinical Development
Neurodegenerative Biomarkers and Treatment Strategies for Neurodegenerative Diseases
An understanding of the complex pathologies involved in patients with neurodegenerative diseases is integral to the identification of biomarkers and potential treatment methods for individuals who suffer from Alzheimer’s, Parkinson’s, and ALS. Here, we look at the development of dedicated biomarker strategies for helping to combat neurodegeneration.
Biomarker Discovery & Development
Interview with Simon Gao, Clinical Imaging Scientist at Genentech
Simon Gao of Genentech discusses his background in clinical imaging and the impact that AI-based approaches may have on biomarker discovery.
Clinical Diagnostics
Untargeted Metabolomics Data Analysis Reinforced by AI/ML Techniques
A key utility of untargeted metabolomics is for detecting key metabolites as indicators of human health and disease status. AI/ML approaches can help to accelerate the verification and validation of metabolomics data.
Spatial Analysis
Xenium: high performance in situ analysis
In Conversation With Michael Schnall-Levin, Chief Technology Officer & Founding Scientist, 10x Genomics
Biomarker Discovery & Development
Blood Markers of Brain Health: The Simoa® Platform—Measuring CNS biomarkers in serum and plasma with ultrasensitivity
With a sensitivity many times greater than traditional ELISA methods, the Simoa® platform can measure brain biomarkers in blood, offering you another dimension of data from a readily available, non-invasive source.
Biomarker Discovery & Development
Lung Cancer Patient Response to Immunotherapy Could be Predicted Through AI-Calculated Biomarker
Breakthroughs in the use of AI for biomarker prediction and validation of efficacy could shape future treatments for immunotherapies. In this case study, we look at its applications in validating lung cancer patient responses to treatment.
